Vertebroplasty is an image-guided therapy in which a cement, a fast-setting polymer, is injected into a pathologic vertebral body. The purpose of this procedure is to relieve pain and disability. It can be used in the setting of painful osteoporotic compression fractures, pathologic fractures from underlying neoplasms, or structurally compromised vertebrae. It has been used for osteoporotic or malignant fractures. The procedure was first described by Galibert et al [1] who found that the “internal casting” provided by polymethyl methacrylate (PMMA) injected into a symptomatic vertebral hemangioma provided substantial pain relief.
With clinical experience and landmark innovation, other indications have emerged. Vertebroplasty can increase patient mobility, decrease narcotic needs, prevent further vertebral collapse resulting in altered forces on intervertebral discs, and avoid the complications associated with prolonged immobility.
Percutaneous vertebroplasty (PVP) usually involves percutaneous injection of PMMA into the vertebral bodies. Occasionally, PMMA has also been placed manually into vertebral lesions during open surgical operations.
Kyphoplasty is often mentioned alongside vertebroplasty. Kyphoplasty differs from vertebroplasty by adding an important additional step: insertion and inflation of a balloon before cement delivery, which also serves to restore vertebral body height and spine alignment. [2] Kyphoplasty is often used interchangeably with vertebroplasty and is considered a subset of vertebroplasty. Spine jack is a new system that corrects vertebral height, reduces the incidence of endplate damage by inserting an implant that mechanically augments the height of the vertebral body to better restore alignment followed by injection of cement.
A normal thoracic spine is immobile and consists of 12 vertebrae. There are important anatomic landmarks to consider including a body, pedicles, laminae, spinous processes, and facet joints. Importantly, thoracic vertebrae have prominent lateral processes that form the articulation with the paired 12 ribs on either side. The 12 vertebrae, 24 ribs, and sternum together form the chest cavity, allowing negative-pressure respiration and providing protection of the chest wall.
Illustration of thoracic vertebrae showing vertebral body, pedicles, facets, transverse process, rib joints, spinous process, and lamina.
The lumbar spine is the next segment of the spine and is more mobile than the thoracic. The lumbar spine typically consists of 5 large vertebrae and important landmarks, including the body, pedicles, lamina, spinous processes, facet joints, and lateral processes. The lumbar spine is mobile with all articulations, contributing to flexion-extension, bending, and rotation allowing for truncal mobility.
Lumbar vertebrae are characterized by massive bodies and robust spinous and transverse processes. Their articular facets are oriented somewhat parasagittally, which is thought to contribute the large range of anteroposterior bending possible between lumbar vertebrae. Lumbar vertebrae also contain small mammillary and accessory processes on their bodies. These bony protuberances are sites of attachment of deep lumbosacral muscles.
This anatomy is important to consider in three-dimensional space and be easily identifiable on X-rays in order to facilitate optimal placement of the needle under fluoroscopic guidance. An important step in understanding these procedures is to have a grasp of radiographic anatomy. (See Technique.)
Indications for percutaneous vertebroplasty include painful, non-healing osteoporotic or neoplastic vertebral compression fractures refractory to medical therapy. When these conditions result in loss of normal vertebral body height, balloon kyphoplasty or vertebral augmentation with implants such as Stryker’s SpineJack system can be utilized in order restore normal vertebral alignment while also treating pain.
For patients that may not be candidates for vertebroplasty (see Contraindications) or choose to not pursue invasive treatment, medical management options are available. Medical treatment of compression fractures consists of bed rest, pain control with non-steroidal anti-inflammatory medications, calcitonin, narcotics, and external bracing. Patients whose compression fractures fail to heal after completion of the aforementioned conservative regimen over a course of 3–6 weeks should be considered for vertebroplasty.
Patients without fractures but pain resulting from lytic metastatic neoplasm or rare symptomatic hemangioma are also candidates for vertebroplasty.
Vertebroplasty can also be performed prophylactically to stabilize a weakened vertebra before a planned surgery.
One of the most common complications of osteoporosis is vertebral fracture that can occur spontaneously or more frequently as a result of minor trauma. In the United States, the incidence of compression fractures is more than 500,000 patients per year with a 16% lifetime risk in women and 5% lifetime risk in men. [4]
These vertebral fractures are often highly painful and can lead to pain-limited immobility, which leads to demineralization and propagation of a vicious cycle of continued demineralization and increased predisposition to fracture. Although the initial symptoms tend to disappear in 4–6 weeks, in many cases some patients have severe, persistent, incapacitating pain despite medical therapy. Consequences of untreated fracture include reduced height, reduction of normal thoracic kyphosis, and chronic back pain.
An important consideration in the discussion of vertebroplasty is the VERTOS study, which directly compared vertebroplasty to medical management. The VERTOS study prospectively compared osteoporotic compression fracture treatment of 18 patients with vertebroplasty to 16 patients with optimal medical management and found improvement in pain relief for the vertebroplasty group. [7] These results were confirmed with the VERTOS II study, a larger prospective randomized trial consisting of 101 patients treated with vertebroplasty and 101 treated with conservative management). [8, 9]
Two important studies to consider are those by Buchbinder et al. and Kallmes et al., each of which compared vertebroplasty to sham procedures and importantly demonstrated no significant improvement with vertebroplasty. [10, 11] This mixed evidence has sparked considerable debate as to the appropriate role of this procedure.
The VERTOS IV study, a randomized control trial published in four community hospitals in the Netherlands, looked at 180 patients comparing vertebroplasty vs sham procedure and did not show any statistically significant greater pain relief than sham procedure during 12 month follow up in patients with osteoporotic compression fractures. [12]
Even after balloon kyphoplasty, osteoporotic compression fractures have a high rate of continued collapse with subsequent loss of height and the development of angulation and deformity. This appears to increase the risk for adjacent level fractures. The SpineJack system (Stryker Corp, Kalamazoo, MI) consists of bilateral expandable titanium implants supplemented with bone cement. This system provides more symmetric and balanced lateral and anterior support, and requires lower volumes of bone cement compared to balloon kyphoplasty. Using this system, clinicians can now achieve better pain control, restore vertebral body height, restore spinal alignment, and reduce the risk of adjacent level fractures.
One important advantage of SpineJack kyphoplasty over standard balloon kyphoplasty or vertebroplasty is the ability to perform kyphoplasty safely in patients with mild–moderate retropulsion of the posterior endplate without neurological compromise. In certain situations, the SpineJack device has been used to elevate the fractured endplates serving to reduce the retropulsed bone fragment. In circumstances where patients have a retropulsed bone fragment, SpineJack is superior for the aforementioned reason. Retropulsed bone fragments are a relative contraindication to balloon kyphoplasty.
This finding was noted in the SAKOS study, which directly compared SpineJack kyphoplasty versus balloon kyphoplasty and showed that SpineJack patients had better pain reduction at 1 month and 6 months post treatment. The SAKOS study also showed that SpineJack is associated with a reduced incidence of adjacent level fractures. [13]
See Technique for further detail.
The role of vertebroplasty in spinal tumors is palliative. Generally, in previously untreated painful vertebral metastasis, radiotherapy is used in 70% of cases to alleviate spinal pain. However, this effect is delayed and often can take up to 2–6 weeks to provide relief. Vertebroplasty can achieve the same goal of pain relief with an almost immediate analgesic effect. [14]
Vertebroplasty has successfully treated severe focal spinal pain with radiologically unaggressive vertebral (body) hemangioma as originally described by Galibert in 1984.
Absolute contraindications: [15]
Fractures that are asymptomatic
Active osteomyelitis of the target vertebra
Coagulopathy that is not amenable to correction
Allergy to cement or opacifying agent used in procedure
Fractures that cause compromise of the spinal canal and subsequent myelopathy or radiculopathy
Relative contraindications: [15]
Significant central canal narrowing from retropulsion of bony fragment or epidural tumor
Ongoing systemic infection
Disruption of the posterior cortex of the vertebral body
Multiple vertebroplasty kits are available. Each manufacturer has their own specific subsets with unique names for the devices, but the basic components are the same: access needle, syringe, cement, and cement mixing apparatus. See individual manufacturers’ guidelines for further information on individual kits.
The most important aspect of planning this procedure is an accurate history and physical exam. It has been shown that localizing tenderness on palpation is not associated with superior vertebroplasty response. [16]
Important information can be obtained from a good history taken on a patient with an acute vertebral compression fracture.
deep pain with sudden onset
midline location
exacerbation by motion and standing
Studies to consider in the evaluation of patients for vertebroplasty include plain film X-ray, CT scan, and MRI of the spine. These three modalities will help determine which vertebra is to be injected.
MRI will allow for evaluation of canal narrowing or osteomyelitis. CT will allow for evaluation of lytic or blastic bone lesion and plain films can be useful for procedural planning.
Obtaining informed consent and a thorough discussion of the risks, benefits, and alternatives is an important aspect of any procedure.
Procedure time can vary but ultimately lasts anywhere from 40 to 120 minutes.
Conscious sedation and local anesthesia are used in the majority of cases. Use of MAC anesthesia has also been described.
Prophylactic antibiotics such as cefazolinshould be considered.
Place the patient in the prone position.
Align posterior ribs to obtain a good lateral view.
On the anteroposterior (AP) view, find the obliquity that projects the pedicle over the upper outer third of the vertebral body. Mark this point.
Radiation exposure is an important consideration when performing these procedures. In a study analyzing 11 cases of vertebroplasty, patient effective doses were estimated at 34mGy with average fluoroscopy times of 28 minutes (in comparison, a typical CT abdomen and pelvis effective dose is 8–14 mGy). Operator exposures were highest to the hands and chest, although there was a decrease in occupational dose by 76% with the use of mobile shielding. It was estimated that an operator could perform 150 procedures annually before exceeding annual dose constraints. [17]
Lidocaine with epinephrine is commonly used for local anesthetic and a spinal needle to anesthetize the periosteum. Proper trajectory may be confirmed with AP and lateral fluoroscopic views. Depending on the size of the pedicle, different gauge needles can be used. 11-gauge is recommended for lumbar and lower thoracic pedicles; but a 13-gauge will suffice midthoracic pedicles.
A large clamp will allow for maintenance of tension along the back to allow for easier placement of the needle. A sterile hammer can be used to gently tap the needle. Direct the needle into the vertebral body, using AP and lateral views for verification.
Percutaneous vertebroplasty, transpedicular approach.
Percutaneous vertebroplasty, transpedicular approach under fluoroscopic guidance, lateral view.
Percutaneous vertebroplasty, transpedicular approach under fluoroscopic guidance, anteroposterior view.
Transpedicular approaches:
For a unipedicular approach, advance needle into the anterior third of the central vertebral body.
For a bipedicular approach, advance needles into the midportion of the hemivertebrae.
A parapedicular approach may be considered as well.
Depending on the manufacturer, there can be different methods to make the cement. Depending on the agent of choice, both polymethylmethacrylate (PMMA) and barium sulfate (opacifying agent) should be made as per the manufacturer's instructions. Slowly inject this mixture until the vertebral body is well filled, making certain to stop before PMMA leaks posteriorly into the epidural area or significantly fills a vein.
An important consideration is the volume of cement used to fill the vertebral body. Pain relief is not associated with cement volume, thus attempting to fill the vertebral body as completely as possible is not necessary. [19]
One of the shortcomings of percutaneous vertebroplasty and even balloon kyphoplasty is a continued rate of collapse. Osteoporotic compression fractures have a high rate of continued collapse with subsequent loss of height and the development of angulation and deformity after these procedures, which increases the risk for adjacent level fractures. The SpineJack system (Stryker Corp, Kalamazoo, MI) consists of bilateral expandable titanium implants supplemented with bone cement. This system provides more symmetric and balanced lateral and anterior support, and requires lower volumes of bone cement compared to balloon kyphoplasty. Using this system, clinicians can now achieve better pain control, restore vertebral body height, restore spinal alignment, and reduce the risk of adjacent level fractures. [20]
The SpineJack system offers three implant kit sizes: 4.2 mm, 5.0 mm, and 5.8 mm. Each kit contains the appropriate instrumentation for the procedure, first for preparation, then for expansion and fracture reduction. The range of sizes accommodates various anatomies and fracture types. The implant expands in a craniocaudal direction and combat compression forces up to 1000N of expansion force.
A pedicle width of 0.8 mm larger than the desired implant size is recommended for safe placement. (e.g. 4.2 mm implant +0.8mm = 5mm minimum pedicle width).
Table. (Open Table in a new window)
Pedicle diameter | Recommended kit |
---|---|
5.0–5.8 mm | 4.2 mm |
5.8–6.6 mm | 5.0 mm |
6.6 mm or greater | 5.8 mm |
Like a vertebroplasty, the Stryker SpineJack system utilizes a bipedicular approach to advance the access cannula to the posterior one third of the vertebral body. Then a guidewire is advanced to the midpoint of the vertebral body, then removal of the access cannula. Then following the path of the guidewire, the reamer is advanced until it is entirely within the vertebral body. Then the template is inserted to clean the implant site and verify the length of the implant. Then the spine jacks are expanded to reduce the fracture and restore anatomy. Then PMMA is advanced and good closure is obtained with adequate hemostasis.
Generally, patients are kept on bed rest for 1–2 hours and given analgesics for postoperative pain with muscle relaxants for spasm. Patients with osteoporosis should be managed medically and closely followed after the procedure. Without systemic osteoporosis therapy, 20% of patients with a fracture develop a second fracture.
Treatment for osteoporosis includes DEXA scans, lifestyle modifications (smoking cessation, alcohol moderation, exercise), dietary supplementation (calcium, vitamin D), and medical management (antiresorptive). [22]
Complications with percutaneous vertebroplasty are more commonly seen with malignant spinal tumors and hemangiomas than with osteoporotic compression fractures. Chiras et al reported incidents and complications in 274 patients with 10% attributable to spinal tumor cases, 2–5% with vertebral hemangioma cases, and 1–3% seen in osteoporotic compression fractures. [23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43]
It is important to counsel patients on the possibility of the following:
Neurologic deficit including paralysis
Positioning or needle-placement related fractures including those of the vertebra, rib, or sternum
Infection
Allergic reaction
Pulmonary embolus
Hemorrhage
Pneumothorax or hemothorax
Cement migration
CT scan should be obtained in any patient who experiences new radicular pain post-procedure. CT scan is particularly useful in patients for which there is a concern for polymethylmethacrylate (PMMA) migration, specifically that into the epidural venous plexus.
CT scan is also useful for assessing patients with severe back pain to assess for a fractured pedicle or transverse process.
New onset regional back pain is suggestive of adjacent level fracture and can be better evaluated with non-contrast MRI. Careful review of the STIR sequence on non-contrasted MRI can help determine the acuity of the fracture.
CT pulmonary angiogram or rib series X-ray can be helpful in patients who develop chest pain in the post-procedure period in addition to a standard EKG. The CT pulmonary angiogram can rule out pulmonary embolus.
Paralysis has been reported but is very uncommon. Precautions should be taken while injecting above L1, with attention to the posterior vertebral body wall; do not allow PMMA to flow into the epidural venous plexus.
Reports are mixed as to whether vertebroplasty predisposes patients to develop additional vertebral fractures. Spine Jack has been shown to have reduced incidence of adjacent level fracture when compared to vertebroplasty or balloon kyphoplasty.
Galibert P, Deramond H, Rosat P, Le Gars D. [Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty]. Neurochirurgie. 1987. 33(2):166-8. [QxMD MEDLINE Link].
Eck JC, Nachtigall D, Humphreys SC, Hodges SD. Comparison of vertebroplasty and balloon kyphoplasty for treatment of vertebral compression fractures: a meta-analysis of the literature. Spine J. 2008 May-Jun. 8 (3):488-97. [QxMD MEDLINE Link].
Dutton M. Dutton's Orthopaedic Examination Evaluation and Intervention. 5th ed. McGraw-Hill Education; 2019.
Lips P. Epidemiology and predictors of fractures associated with osteoporosis. Am J Med. 1997 Aug 18. 103 (2A):3S-8S; discussion 8S-11S. [QxMD MEDLINE Link].
Tian QH, Wu CG, Xiao QP, He CJ, Gu YF, Wang T, et al. Percutaneous vertebroplasty of the entire thoracic and lumbar vertebrae for vertebral compression fractures related to chronic glucocorticosteriod use: case report and review of literature. Korean J Radiol. 2014 Nov-Dec. 15 (6):797-801. [QxMD MEDLINE Link].
Langdon J, Way A, Heaton S, Bernard J, Molloy S. Vertebral compression fractures--new clinical signs to aid diagnosis. Ann R Coll Surg Engl. 2010 Mar. 92 (2):163-6. [QxMD MEDLINE Link].
Voormolen MH, Mali WP, Lohle PN, Fransen H, Lampmann LE, van der Graaf Y, et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short-term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. AJNR Am J Neuroradiol. 2007 Mar. 28 (3):555-60. [QxMD MEDLINE Link].
Klazen CA, Lohle PN, de Vries J, Jansen FH, Tielbeek AV, Blonk MC, et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial. Lancet. 2010 Sep 25. 376 (9746):1085-92. [QxMD MEDLINE Link].
Klazen CA, Verhaar HJ, Lampmann LE, Juttmann JR, Blonk MC, Jansen FH, et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials. 2007 Oct 31. 8:33. [QxMD MEDLINE Link].
Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt C, et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med. 2009 Aug 6. 361 (6):557-68. [QxMD MEDLINE Link].
Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, Wilson DJ, Diamond TH, et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med. 2009 Aug 6. 361 (6):569-79. [QxMD MEDLINE Link].
Firanescu CE, de Vries J, Lodder P, Venmans A, Schoemaker MC, Smeets AJ, et al. Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ. 2018 May 9. 361:k1551. [QxMD MEDLINE Link].
Noriega D, Marcia S, Theumann N, Blondel B, Simon A, Hassel F, et al. A prospective, international, randomized, noninferiority study comparing an implantable titanium vertebral augmentation device versus balloon kyphoplasty in the reduction of vertebral compression fractures (SAKOS study). Spine J. 2019 Nov. 19 (11):1782-1795. [QxMD MEDLINE Link].
Allegretti L, Mavilio N, Fiaschi P, Bragazzi R, Pacetti M, Castelletti L, et al. Intra-operative vertebroplasty combined with posterior cord decompression. A report of twelve cases. Interv Neuroradiol. 2014 Oct 31. 20 (5):583-90. [QxMD MEDLINE Link].
[Guideline] American College of Radiology. Practice Guideline for the Performance of Vertebroplasty.
Rad AE, Kallmes DF. Pain relief following vertebroplasty in patients with and without localizing tenderness on palpation. AJNR Am J Neuroradiol. 2008 Oct. 29 (9):1622-6. [QxMD MEDLINE Link].
Fitousi NT, Efstathopoulos EP, Delis HB, Kottou S, Kelekis AD, Panayiotakis GS. Patient and staff dosimetry in vertebroplasty. Spine (Phila Pa 1976). 2006 Nov 1. 31 (23):E884-9; discussioin E890. [QxMD MEDLINE Link].
Chen C, Li D, Wang Z, Li T, Liu X, Zhong J. Safety and Efficacy Studies of Vertebroplasty, Kyphoplasty, and Mesh-Container-Plasty for the Treatment of Vertebral Compression Fractures: Preliminary Report. PLoS One. 2016. 11 (3):e0151492. [QxMD MEDLINE Link].
Kaufmann TJ, Trout AT, Kallmes DF. The effects of cement volume on clinical outcomes of percutaneous vertebroplasty. AJNR Am J Neuroradiol. 2006 Oct. 27 (9):1933-7. [QxMD MEDLINE Link].
Jacobson RE, Nenov A, Duong HD. Re-expansion of Osteoporotic Compression Fractures Using Bilateral SpineJack Implants: Early Clinical Experience and Biomechanical Considerations. Cureus. 2019 Apr 30. 11 (4):e4572. [QxMD MEDLINE Link].
Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, et al. Risk of new vertebral fracture in the year following a fracture. JAMA. 2001 Jan 17. 285 (3):320-3. [QxMD MEDLINE Link].
Kearns AE, Kallmes DF. Osteoporosis primer for the vertebroplasty practitioner: expanding the focus beyond needles and cement. AJNR Am J Neuroradiol. 2008 Nov. 29 (10):1816-22. [QxMD MEDLINE Link].
Chiras J, Depriester C, Weill A, Sola-Martinez MT, Deramond H. [Percutaneous vertebral surgery. Technics and indications]. J Neuroradiol. 1997 Jun. 24 (1):45-59. [QxMD MEDLINE Link].
Trout AT, Kallmes DF. Does vertebroplasty cause incident vertebral fractures? A review of available data. AJNR Am J Neuroradiol. 2006 Aug. 27 (7):1397-403. [QxMD MEDLINE Link].
Bostrom MP, Lane JM. Future directions. Augmentation of osteoporotic vertebral bodies. Spine (Phila Pa 1976). 1997 Dec 15. 22 (24 Suppl):38S-42S. [QxMD MEDLINE Link].
Cardon T, Hachulla E, Flipo RM, Chastanet P, Rose C, Deprez X, et al. Percutaneous vertebroplasty with acrylic cement in the treatment of a Langerhans cell vertebral histiocytosis. Clin Rheumatol. 1994 Sep. 13 (3):518-21. [QxMD MEDLINE Link].
Chiras J, Sola-Martinez MT, Weill A, Rose M, Cognard C, Martin-Duverneuil N. [Percutaneous vertebroplasty]. Rev Med Interne. 1995. 16 (11):854-9. [QxMD MEDLINE Link].
Cortet B, Cotten A, Boutry N, Dewatre F, Flipo RM, Duquesnoy B, et al. Percutaneous vertebroplasty in patients with osteolytic metastases or multiple myeloma. Rev Rhum Engl Ed. 1997 Mar. 64 (3):177-83. [QxMD MEDLINE Link].
Cortet B, Cotten A, Boutry N, Flipo RM, Duquesnoy B, Chastanet P, et al. Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: an open prospective study. J Rheumatol. 1999 Oct. 26 (10):2222-8. [QxMD MEDLINE Link].
Cotten A, Dewatre F, Cortet B, Assaker R, Leblond D, Duquesnoy B, et al. Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up. Radiology. 1996 Aug. 200 (2):525-30. [QxMD MEDLINE Link].
Cotten A, Duquesnoy B. Vertebroplasty: current data and future potential. Rev Rhum Engl Ed. 1997 Nov. 64 (11):645-9. [QxMD MEDLINE Link].
Dean JR, Ison KT, Gishen P. The strengthening effect of percutaneous vertebroplasty. Clin Radiol. 2000 Jun. 55 (6):471-6. [QxMD MEDLINE Link].
Deramond H, Depriester C, Toussaint P. [Vertebroplasty and percutaneous interventional radiology in bone metastases: techniques, indications, contra-indications]. Bull Cancer Radiother. 1996. 83 (4):277-82. [QxMD MEDLINE Link].
Dudeney S, Lieberman I. Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: an open prospective study. J Rheumatol. 2000 Oct. 27 (10):2526. [QxMD MEDLINE Link].
Gangi A, Kastler BA, Dietemann JL. Percutaneous vertebroplasty guided by a combination of CT and fluoroscopy. AJNR Am J Neuroradiol. 1994 Jan. 15 (1):83-6. [QxMD MEDLINE Link].
Grados F, Depriester C, Cayrolle G, Hardy N, Deramond H, Fardellone P. Long-term observations of vertebral osteoporotic fractures treated by percutaneous vertebroplasty. Rheumatology (Oxford). 2000 Dec. 39 (12):1410-4. [QxMD MEDLINE Link].
Jensen ME, Dion JE. Percutaneous vertebroplasty in the treatment of osteoporotic compression fractures. Neuroimaging Clin N Am. 2000 Aug. 10 (3):547-68. [QxMD MEDLINE Link].
Kaemmerlen P, Thiesse P, Bouvard H, Biron P, Mornex F, Jonas P. [Percutaneous vertebroplasty in the treatment of metastases. Technic and results]. J Radiol. 1989 Oct. 70 (10):557-62. [QxMD MEDLINE Link].
Lee MJ, Dumonski M, Cahill P, Stanley T, Park D, Singh K. Percutaneous treatment of vertebral compression fractures: a meta-analysis of complications. Spine (Phila Pa 1976). 2009 May 15. 34 (11):1228-32. [QxMD MEDLINE Link].
Murphy KJ, Deramond H. Percutaneous vertebroplasty in benign and malignant disease. Neuroimaging Clin N Am. 2000 Aug. 10 (3):535-45. [QxMD MEDLINE Link].
Padovani B, Kasriel O, Brunner P, Peretti-Viton P. Pulmonary embolism caused by acrylic cement: a rare complication of percutaneous vertebroplasty. AJNR Am J Neuroradiol. 1999 Mar. 20 (3):375-7. [QxMD MEDLINE Link].
Patel G, Singh S, Singh M. Percutaneous vertebroplasty: minimally invasive procedure for vertebral fracture. 2001.
Rapado A. General management of vertebral fractures. Bone. 1996 Mar. 18 (3 Suppl):191S-196S. [QxMD MEDLINE Link].
Rousing R, Andersen MO, Jespersen SM, Thomsen K, Lauritsen J. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three-months follow-up in a clinical randomized study. Spine (Phila Pa 1976). 2009 Jun 1. 34 (13):1349-54. [QxMD MEDLINE Link].
Singh, S. Percutaneous vertebroplasty. Waldman SD. Interventional Pain Management. 2nd ed. Philadelphia: WB Saunders Co; 2001. 707-12.
Tamayo-Orozco J, Arzac-Palumbo P, Peón-Vidales H, Mota-Bolfeta R, Fuentes F. Vertebral fractures associated with osteoporosis: patient management. Am J Med. 1997 Aug 18. 103 (2A):44S-48S; discussion 48S-50S. [QxMD MEDLINE Link].
Trout AT, Kallmes DF, Gray LA, Goodnature BA, Everson SL, Comstock BA, et al. Evaluation of vertebroplasty with a validated outcome measure: the Roland-Morris Disability Questionnaire. AJNR Am J Neuroradiol. 2005 Nov-Dec. 26 (10):2652-7. [QxMD MEDLINE Link].
Noriega D, Marcia S, Theumann N, Blondel B, Simon A, Hassel F, et al. A prospective, international, randomized, noninferiority study comparing an implantable titanium vertebral augmentation device versus balloon kyphoplasty in the reduction of vertebral compression fractures (SAKOS study). Spine J. 2019 Nov. 19 (11):1782-1795. [QxMD MEDLINE Link].
Noriega DC, Rodrίguez-Monsalve F, Ramajo R, Sánchez-Lite I, Toribio B, Ardura F. Long-term safety and clinical performance of kyphoplasty and SpineJack® procedures in the treatment of osteoporotic vertebral compression fractures: a pilot, monocentric, investigator-initiated study. Osteoporos Int. 2019 Mar. 30 (3):637-645. [QxMD MEDLINE Link].
Crespo-Sanjuán J, Ardura F, Hernández-Ramajo R, Noriega DC. Requirements for a Stable Long-Term Result in Surgical Reduction of Vertebral Fragility Fractures. World Neurosurg. 2017 Sep. 105:137-144. [QxMD MEDLINE Link].
Noriega DC, Ramajo RH, Lite IS, Toribio B, Corredera R, Ardura F, et al. Safety and clinical performance of kyphoplasty and SpineJack(®) procedures in the treatment of osteoporotic vertebral compression fractures: a pilot, monocentric, investigator-initiated study. Osteoporos Int. 2016 Jun. 27 (6):2047-55. [QxMD MEDLINE Link].
Lin JH, Wang SH, Lin EY, Chiang YH. Better Height Restoration, Greater Kyphosis Correction, and Fewer Refractures of Cemented Vertebrae by Using an Intravertebral Reduction Device: a 1-Year Follow-up Study. World Neurosurg. 2016 Jun. 90:391-396. [QxMD MEDLINE Link].
Renaud C. Treatment of vertebral compression fractures with the cranio-caudal expandable implant SpineJack®: Technical note and outcomes in 77 consecutive patients. Orthop Traumatol Surg Res. 2015 Nov. 101 (7):857-9. [QxMD MEDLINE Link].
Noriega D, Maestretti G, Renaud C, Francaviglia N, Ould-Slimane M, Queinnec S, et al. Clinical Performance and Safety of 108 SpineJack Implantations: 1-Year Results of a Prospective Multicentre Single-Arm Registry Study. Biomed Res Int. 2015. 2015:173872. [QxMD MEDLINE Link].
Noriega D, Krüger A, Ardura F, Hansen-Algenstaedt N, Hassel F, Barreau X, et al. Clinical outcome after the use of a new craniocaudal expandable implant for vertebral compression fracture treatment: one year results from a prospective multicentric study. Biomed Res Int. 2015. 2015:927813. [QxMD MEDLINE Link].
Vanni D, Pantalone A, Bigossi F, Pineto F, Lucantoni D, Salini V. New perspective for third generation percutaneous vertebral augmentation procedures: Preliminary results at 12 months. J Craniovertebr Junction Spine. 2012 Jul. 3 (2):47-51. [QxMD MEDLINE Link].
Arabmotlagh M, Nikoleiski SC, Schmidt S, Rauschmann M, Rickert M, Fleege C. Radiological evaluation of kyphoplasty with an intravertebral expander after osteoporotic vertebral fracture. J Orthop Res. 2019 Feb. 37 (2):457-465. [QxMD MEDLINE Link].
Muñoz Montoya JE, Torres C, Ferrer ER, Muñoz Rodríguez EE. A Colombian experience involving SpineJack®, a consecutive series of patients experiencing spinal fractures, percutaneous approach and anatomical restoration 2016-2017. J Spine Surg. 2018 Sep. 4 (3):624-629. [QxMD MEDLINE Link].
Ortin-Barcelo A, Ortolà Morales DJ, Rosa MA, Fenga D, Bañuls-Pattarelli MA, Lopez-Prats FA. Adjacent Single-level Combined Fixation Using Kyphoplasty and Percutaneous Pedicle Screws in Type A3 Unstable Vertebral Fractures in Elderly Patients. Folia Med (Plovdiv). 2018 Sep 1. 60 (3):474-478. [QxMD MEDLINE Link].
Premat K, Vande Perre S, Cormier É, Shotar E, Degos V, Morardet L, et al. Vertebral augmentation with the SpineJack® in chronic vertebral compression fractures with major kyphosis. Eur Radiol. 2018 Dec. 28 (12):4985-4991. [QxMD MEDLINE Link].
Vanni D, Pantalone A, Magliani V, Salini V, Berjano P. Corpectomy and expandable cage replacement versus third generation percutaneous augmentation system in case of vertebra plana: rationale and recommendations. J Spine Surg. 2017 Sep. 3 (3):379-386. [QxMD MEDLINE Link].
Lonjon N, Le Corre M, Le Roy J, Greffier J, Fuentes S, Tonetti J, et al. Surgeon's and Patient's Radiation Exposure Through Vertebral Body Cement Augmentation Procedures: A Prospective Multicentric Study of 49 Cases. World Neurosurg. 2016 Sep. 93:371-6. [QxMD MEDLINE Link].
Baeesa SS, Krueger A, Aragón FA, Noriega DC. The efficacy of a percutaneous expandable titanium device in anatomical reduction of vertebral compression fractures of the thoracolumbar spine. Saudi Med J. 2015 Jan. 36 (1):52-60. [QxMD MEDLINE Link].
Wu CC, Lin MH, Yang SH, Chen PQ, Shih TT. Surgical removal of extravasated epidural and neuroforaminal polymethylmethacrylate after percutaneous vertebroplasty in the thoracic spine. Eur Spine J. 2007 Dec. 16 Suppl 3:326-31. [QxMD MEDLINE Link].
Admin
Link nội dung: https://pi-web.eu/percutaneous-vertebroplasty-overview-indications-contraindications-1732839008-a3615.html